Applied microbiology articles from across Nature Portfolio

Existing carbon capture and utilization technologies are hindered by significant energy penalties. Here, the authors discuss the Bio-Integrated Carbon Capture and Utilization (BICCU) technology, which mitigates the energy penalties while generating valuable C1 and C2 products.

Here, the authors develop the Gut Microbiome Wellness Index 2 (GMWI2), an enhanced version of the original GMWI prototype, designed as a disease-agnostic health status indicator based on gut microbiome taxonomic profiles.

Yeast is a widely used cell factory for the conversion of sugar into fuels, chemicals and pharmaceuticals. Establishing yeast as being autotrophic can enable it to grow solely on CO₂ and light, and hereby yeast can be used as a wider platform for transition to a sustainable society.

In this study, Hiis et al. demonstrate that the N₂O-respiring bacterial strain Cloacibacterium sp. CB-01 can reduce nitrous oxide emissions from soil.

Decomposer microbiomes are universal across cadavers regardless of environmental conditions, and they use complex cross-feeding and interkingdom interactions to break down organic matter.

In this study, Knödlseder et al. explore the potential of an engineered Cutibacterium acnes strain as a microbiome-based therapy for skin conditions.

Scientific research on human insulin was a crucial development in medicine, and its discovery led to the treatment of diabetes, one of the most prevalent global chronic diseases. A seminal work published in 1979 describing recombinant DNA technology to produce human insulin through biocatalysis has resulted in this field’s establishment and routine industrial applications.